We would like to thank Sookaromdeel and Wiwanitkit for their interest in our paper and for taking the time to express their opinion (1). Sahin et al. showed as BNT162b2 mRNA vaccine induces robust and protective humoral and cellular responses to SARS-CoV-2 spike protein (2). While immunocompetent individuals have detectable antibodies after the second vaccination, combined analysis with cellular immunity is superior in identifying vaccine responders among post-transplant individuals (3).
Reply to: Seroconversion after COVID-19 vaccination (LT-21-741)
Calleri A.;Saracco M.;Cavallo R.;Romagnoli R.;Martini S.
2021-01-01
Abstract
We would like to thank Sookaromdeel and Wiwanitkit for their interest in our paper and for taking the time to express their opinion (1). Sahin et al. showed as BNT162b2 mRNA vaccine induces robust and protective humoral and cellular responses to SARS-CoV-2 spike protein (2). While immunocompetent individuals have detectable antibodies after the second vaccination, combined analysis with cellular immunity is superior in identifying vaccine responders among post-transplant individuals (3).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
17227091.pdf
Accesso riservato
Descrizione: Articolo principale
Tipo di file:
PDF EDITORIALE
Dimensione
69.8 kB
Formato
Adobe PDF
|
69.8 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
